| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.26 ▲ +2.03% | Yesterday | $3.17 ▼ -0.85% | Tomorrow's Nasus Pharma Ltd. Ordinary Shares (NSRX) setup is anchored to $3.20 and targets $3.26 (+2.03%). The near-term read is upside; watch $3.30 / $3.10 because daily realized volatility is about 8.00%. |
Tomorrow's Nasus Pharma Ltd. Ordinary Shares (NSRX) setup is anchored to $3.20 and targets $3.26 (+2.03%). The near-term read is upside; watch $3.30 / $3.10 because daily realized volatility is about 8.00%. | ||||
| Week | $3.40 ▲ +6.31% | Last Week | $3.12 ▼ -2.65% | The 7-day Nasus Pharma Ltd. Ordinary Shares model moves from $3.12 to $3.40 (+6.31%). It gives upside momentum context for this stock, so breaks around $3.30 / $3.10 matter more than a single tick. |
The 7-day Nasus Pharma Ltd. Ordinary Shares model moves from $3.12 to $3.40 (+6.31%). It gives upside momentum context for this stock, so breaks around $3.30 / $3.10 matter more than a single tick. | ||||
| Month | $3.63 ▲ +13.45% | Last Month | $3.02 ▼ -5.65% | The 1-month Nasus Pharma Ltd. Ordinary Shares target is $3.63 (+13.45%), compared with the live reference near $3.20. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Nasus Pharma Ltd. Ordinary Shares target is $3.63 (+13.45%), compared with the live reference near $3.20. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.97 ▲ +24.14% | Last Year | $2.88 ▼ -10.14% | The 1-year Nasus Pharma Ltd. Ordinary Shares scenario points to $3.97 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Nasus Pharma Ltd. Ordinary Shares scenario points to $3.97 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.77 ▲ +49.20% | 5 Years Ago | $2.54 ▼ -20.66% | The 5-year Nasus Pharma Ltd. Ordinary Shares view is $4.77 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Nasus Pharma Ltd. Ordinary Shares view is $4.77 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $3.20 | Mid |
| Daily Change | +11.89% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 83% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $3.20 | Daily Change | +11.89% |
| Market Cap | $37.47M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.